Why are some medicines injectable, while others come as tablets? What are the specific challenges of manufacturing drugs for neglected diseases? Why is acoziborole – our new sleeping sickness pill – white? Why does the design of drug packaging require so much thought? And how do we ensure the consistent quality of our medicines? Dr Stephen Robinson, Pharmaceutical Development Director at DNDi answers all these questions and more.